Table 3

Reasons for non-adherence to the treatment advice of the treat-to-target strategy

Remission

(DAS28 < 2.6)

(n = 553)

Non-remission

(DAS28 ≥ 2.6)

(n = 539)


Tapering off/discontinuing instead of continuing

40 (7.2)

Unknown

12

Patient wish

3

Side effects

19

Clinical remission

5

Other

1

Continuing instead of tapering off/discontinuing

34 (6.2)

.

Unknown

23

Patient wish

4

Active disease

5

Other

2

Intensifying instead of not intensifying*

24 (4.3)

.

Unknown

2

Patient wish

2

Active disease

20

Not intensifying* instead of intensifying

.

188 (34.9)

Unknown

29

Patient wish

13

Side effects

32

Clinical remission

106

Other

8

Other deviations from treatment advice

10 (1.8)

39 (7.2)

Unknown

5

10

Patient wish

.

2

Side effects

4

16

Clinical remission

.

2

Other

1

9


Data are presented of a total of 1097 visits of 100 patients with early rheumatoid arthritis, stratified by remission state according to the Disease Activity Score in 28 joints (DAS28). Values regarding the type of deviation are presented as number (%), values regarding the reasons for non-adherence are presented as number. *Including continuing, tapering off and discontinuing medication.

Vermeer et al. Arthritis Research & Therapy 2012 14:R254   doi:10.1186/ar4099

Open Data